Food and Drug Administration, Dockets Management Branch, 5630 Fishers Lane - Room 1061- HFA-305, Rockville, MD, 20852; 301-827-6860; Fax 301-827-6870  [E-mail]  

DOCKETS ENTERED on May 31, 2000

Table of Contents

(Hyper links are part of the Docket  title - not all dockets/documents are linked)

[FDA DOCKETS PAGE][FDA HOME PAGE]  [ ITEM CODES ]

 
97S-0162 30-Day Structure Function Claim Notification Letters Dietary *
99P-3030 Health Claim: Saw Palmetto & Benign Prostatic Hyperplasia *
00D-1223 Clinical Investigation of Medicinal Products in Pediatrics *
00F-0792 OLESTRA BE AMENDED REMOVING REQUIREMENT FOR LABEL STATEMENT *
00N-1256 Over-the-Counter Drug Products;Public Hearing *
00P-1319 Performance Standard for Electrode Lead Wires & Patient Cabl *
00P-1320 *
00P-1322 Food Labeling and Allergen Contamination Control *
00P-1324 Propoxyphene Napsylate/Acetaminophen 100 Mg/500mg *
00V-1323 Laser Light Show*
97S-0162 30-Day Structure Function Claim Notification Letters Dietary

LET 4620 New Chapter, Inc. Vol#: 35

LET 4621 New Chapter, Inc. Vol#: 35

LET 4622 New Chapter, Inc. Vol#: 35

LET 4623 New Chapter, Inc. Vol#: 35

LET 4624 New Chapter, Inc. Vol#: 35

LET 4625 New Chapter, Inc. Vol#: 35

LET 4626 New Chapter, Inc. Vol#: 35

LET 4627 New Chapter, Inc. Vol#: 35

LET 4628 New Chapter, Inc. Vol#: 35

LET 4629 New Chapter, Inc. Vol#: 35

LET 4630 Provenance Vol#: 35

LET 4631 Atkins Nutritionals, Inc. Vol#: 35

LET 4632 Pharmanex Vol#: 35

LET 4633 Pharmanex Vol#: 35

LET 4634 Pharmanex Vol#: 35

LET 4635 Pharmanex Vol#: 35

LET 4636 Pharmanex Vol#: 35

LET 4637 Pharmanex Vol#: 35

LET 4638 Pharmanex Vol#: 35

LET 4639 Pharmanex Vol#: 35

LET 4640 Pharmanex Vol#: 35

LET 4641 Pharmanex Vol#: 35

LET 4642 Pharmanex Vol#: 35

LET 4643 Pharmanex Vol#: 35

LET 4644 Pharmanex Vol#: 35

LET 4645 Pharmanex Vol#: 35

LET 4646 Pharmanex Vol#: 5

LET 4647 Pharmanex Vol#: 35

LET 4648 Pharmanex Vol#: 35

LET 4649 Pharmanex Vol#: 35

LET 4650 Pharmanex Vol#: 35

LET 4651 Pharmanex Vol#: 35

LET 4652 Pharmanex Vol#: 35

LET 4653 Pharmanex Vol#: 35

LET 4654 Pharmanex Vol#: 35

LET 4655 Pharmanex Vol#: 35

LET 4656 Pharmanex Vol#: 35

LET 4657 Pharmanex Vol#: 35

LET 4658 Pharmanex Vol#: 35

LET 4659 Pharmanex Vol#: 35

LET 4660 Pharmanex Vol#: 35

LET 4661 Pharmanex Vol#: 35

LET 4662 Pharmanex Vol#: 35

LET 4663 Pharmanex Vol#: 35

LET 4664 Jarrow Formulas, Inc. Vol#: 35

LET 4665 Jarrow Formulas, Inc. Vol#: 35

LET 4666 Jarrow Formulas, Inc. Vol#: 35

LET 4667 Jarrow Formulas, Inc. Vol#: 35

LET 4668 Jarrow Formulas, Inc. Vol#: 35

LET 4669 Concepts In Confidence Vol#: 35

LET 4670 Kleos Laboratories Vol#: 35

LET 4671 Nikken Inc. Vol#: 35

LET 4672 L. G. Laboratories Vol#: 35

LET 4673 Pharmanex Vol#: 35

LET 4674 The Winning Combination Vol#: 35

LET 4675 Doctor's Best, Inc. Vol#: 35

LET 4676 Doctor's Best, Inc. Vol#: 35

LET 4677 Doctor's Best, Inc. Vol#: 35

LET 4678 Viva Vol#: 35

LET 4679 Doctor's Best, Inc. Vol#: 35

LET 4680 Isula Rain Ltd. Vol#: 35

LET 4681 Isula Rain Ltd. Vol#: 35

LET 4682 Isula Rain Ltd. Vol#: 35

LET 4683 Isula Rain Ltd. Vol#: 35

LET 4684 Isula Rain Ltd. Vol#: 35

LET 4685 Isula Rain Ltd. Vol#: 35

LET 4686 Isula Rain Ltd. Vol#: 35

LET 4687 Isula Rain Ltd. Vol#: 35

LET 4688 Isula Rain Ltd. Vol#: 35

LET 4689 Murdock Madaus Schwabe Vol#: 36

LET 4690 NBTY Inc Vol#: 36

LET 4691 Murdock Madaus Schwabe Vol#: 36

LET 4692 NBTY Inc Vol#: 36

LET 4693 NBTY Inc Vol#: 36

LET 4694 NBTY Inc Vol#: 36

LET 4695 NBTY Inc Vol#: 36

LET 4696 NBTY Inc Vol#: 36

LET 4697 NBTY Inc Vol#: 36

99D-4575 New Use of a Food Contact Substance Notification System

N 1 Vol#: 1

99D-4576 New Use of a Food Contact Substance Notification Systems

N 1 Vol#: 1

99P-3030 Health Claim: Saw Palmetto & Benign Prostatic Hyperplasia

PDN 2 HFS-001 To Emord & Associates P.C. Vol#: 6

REF 1 HFS-001 Vol#: 7

REF 2 HFS-001 Vol#: 7

00D-1223 Clinical Investigation of Medicinal Products in Pediatrics

C 2 DuPont Pharmaceuticals Company Vol#: 1

C 3 Alcon Research, LTD Vol#: 1

C 4 PHRMA Vol#: 1

C 5 Pharmacia Corporation Vol#: 1

C 6 Infections Diseases Society of America Vol#: 1

C 7 Royal College of Paediatrics & Child Hth Vol#: 1

C 8 Lomond & Argyll Primary Care NHS Trust Vol#: 1

C 9 Royal Brompton & Harefield NHS Trust Vol#: 1

C 10 Confederation of European Specialists Pe Vol#: 1

C 11 Eye-Care Industries Vol#: 1

C 12 Merck Sharp & Dohme (Europe) Inc Vol#: 1

C 13 European Federation of Pharmaceutical In Vol#: 1

EMC 1 Robert M. Nelson Vol#: 1

LET 1 DHHS Vol#: 1

00F-0786 Safe Use of Chlorine Dioxide

FONS1 Finding Of No Significant Impact Vol#: 1

NFR 1 Vol#: 1

00F-0792 OLESTRA BE AMENDED REMOVING REQUIREMENT FOR LABEL STATEMENT

EMC 1 John Peters, Constance Frederickson Vol#: 10

00N-1256 Over-the-Counter Drug Products;Public Hearing

APE 26 SmithKline Beecham Vol#: 2

APE 27 Chris Kahlenborn, MD Vol#: 2

APE 28 AMMSYS Research Inc. Vol#:

APE 29 Covington & Burling Vol#: 2

APE 30 JCAAI Vol#: 2

APE 31 Bennett, Turner & Coleman, LLP Vol#: 2

CH 28 Margaret Karam Vol#: 1

CH 29 Crisis Pregnancy Center Vol#: 1

CH 30 PCA Primary Care Associates Vol#: 1

00P-1319 Performance Standard for Electrode Lead Wires & Patient Cabl

ACK 1 HFA-305 Vol#: 1

CP 1 IOMED, Inc. Vol#: 1

00P-1320

ACK 1 HFA-305 Vol#: 1

CP 1 Allegiance Healthcare Corporation Vol#: 1

00P-1322 Food Labeling and Allergen Contamination Control

ACK 1 HFA-305 Vol#: 1

CP 1 State of New York Vol#: 1

00P-1324 Propoxyphene Napsylate/Acetaminophen 100 Mg/500mg

ACK 1 HFA-305 Vol#: 1

CP 1 Mikart, Inc Vol#: 1

00V-1323 Laser Light Show

ACK 1 HFA-305 Vol#: 1

VAR 1 Allen Memorial Planetarium Vol#: 1